| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3637831 | F | GSK_TB: Minimum inhibitory concentration against H37Rv stain of Mycobacterium tuberculosis using MABA method | Mycobacterium tuberculosis H37Rv | 50 | ALA3637782 | organism-based format | GSK Tuberculosis Screening | |
| 2. | ALA3637832 | F | GSK_TB: Effect of compound calculated as % inhibition at single shot or pIC50 ( pIC50 ATP assay M.bovis) | Mycobacterium bovis | 50 | ALA3637782 | organism-based format | GSK Tuberculosis Screening | |
| 3. | ALA3637833 | F | GSK_TB: Inhibition of the intracellular growth of Mycobacterium tuberculosis (pXC50) | Mycobacterium tuberculosis H37Rv | 47 | ALA3637782 | organism-based format | GSK Tuberculosis Screening | |
| 4. | ALA3637835 | F | GSK_TB: Activity against non-replicating Mycobacterium tuberculosis (% inhibition) | Mycobacterium tuberculosis H37Rv | 50 | ALA3637782 | organism-based format | GSK Tuberculosis Screening | |
| 5. | ALA3637837 | F | GSK_TB: The cytotoxicity against HepG2 cells expressed as IC50 | Homo sapiens | 50 | ALA3637782 | cell-based format | GSK Tuberculosis Screening | |
| 6. | ALA3637838 | P | GSK_TB: Kinetic solubility of the compound in phosphate buffered saline at pH 7.4 after 1 hr by CLND method | 49 | ALA3637782 | small-molecule physicochemical format | GSK Tuberculosis Screening | ||
| 7. | ALA3637839 | P | GSK_TB: Lipophilicity, log D of the compound at pH 7.4 by ChromlogD analysis | 50 | ALA3637782 | small-molecule physicochemical format | GSK Tuberculosis Screening |
The page will load shortly, Thanks for your patience!